Variables | Hazard ratio | 95% confidence interval | P value |
---|---|---|---|
Gender - Female | 0.657 | 0.313–1.376 | 0.265 |
Age | 0.973 | 0.946–1.000 | 0.052 |
AFP | 1.000 | 1.000–1.000 | 0.005 |
PIVKA-II | 1.001 | 1.000–1.001 | 0.128 |
Locoregional therapy | 1.495 | 0.848–2.634 | 0.165 |
White blood cells | 0.961 | 0.835–1.107 | 0.582 |
Hemoglobin | 1.010 | 0.853–1.195 | 0.909 |
Platelet counts | 1.000 | 0.998–1.003 | 0.821 |
INR | 6.056 | 0.254–144.219 | 0.266 |
Albumin | 0.533 | 0.290–0.980 | 0.043 |
Total bilirubin | 1.047 | 0.654–1.676 | 0.849 |
AST | 1.005 | 0.999–1.011 | 0.103 |
ALT | 1.002 | 0.996–1.008 | 0.565 |
ALP | 1.002 | 0.995–1.008 | 0.643 |
Creatinine | 0.427 | 0.091–2.004 | 0.281 |
Estimated GFR | 1.015 | 0.997–1.033 | 0.102 |
GGT | 1.000 | 0.998–1.001 | 0.739 |
CRP | 1.133 | 1.028–1.249 | 0.012 |
Operation (non-anatomical) | 1.473 | 0.863–2.515 | 0.156 |
Hepatectomy (minor) | 0.922 | 0.367–2.315 | 0.863 |
Maximum tumor size | 1.003 | 0.997–1.010 | 0.282 |
Grade (3 and 4) | 0.627 | 0.311–1.267 | 0.194 |
Cirrhosis | 1.426 | 0.879–2.314 | 0.150 |
Capsule formation | 1.020 | 0.353–2.941 | 0.971 |
Capsular invasion | 0.715 | 0.439–1.165 | 0.178 |
Bile duct invasion | 0.752 | 0.302–1.873 | 0.540 |
Serosa involvement | 5.863 | 1.372–25.058 | 0.017 |
Intrahepatic metastasis | 1.787 | 1.098–2.910 | 0.020 |
Multicentric occurrence | 0.048 | 0.00–195.191 | 0.474 |
Margin (mm) | 1.006 | 0.986–1.026 | 0.566 |